Navigation Links
Aethlon Medical to Discuss Recent Progress at the LHA Life Sciences & Medical Technologies Virtual Conference on June 16
Date:6/7/2011

s from the entire circulatory system without the loss of essential blood components or its ability to eliminate the need to infuse drug agents into the body, the Company's ability to commercialize its Hemopurifier® in India, the capability of the Hemopurifier® to reduce viral loads and other disease conditions or to identify or treat disease conditions such as cancer or Hepatitis-C, including the ability to capture exosomes and the impact that potential ability may have on disease conditions, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the ability of the Company to obtain FDA and other regulatory approvals permitting the sale of its products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings.

Contacts:

James A. Joyce
Chairman and CEO
858.459.7800 x301
jj@aethlonmedical.com

Jody Cain
Senior Vice President, Lippert/Heilshorn & Associates
310.691.7100
jcain@lhai.com

Jim Frakes
Chief Financial Officer
858.459.7800 x300
jfrakes@aethlonmedical.com

John P. Salvador
Director, Communications & Investor Relations
858.459.7800 x307
jps@aethlonmedical.com


'/>"/>
SOURCE Aethlon Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Aethlon Medical to Present the Aethlon ADAPT™ System at C21 BioVentures™ Life Sciences Partnering Conference
2. Aethlon Medical Clarifies News Report
3. ABC News Reports on Aethlon Medical
4. Aethlon Medical Announces Multi-Target Exosome Assay Validation
5. Aethlon Medical Releases Shareholder Letter
6. Aethlon Medical Receives FDA Approval to Export its Hemopurifier® to India
7. Aethlon Medical Releases Shareholder Letter
8. Aethlon Medical to Host Investor Event on January 20, 2011
9. Aethlon Medical Announces Presentation at U.S. Department of Health and Human Services BARDA Industry Day
10. A Platform Technology to Address Bioterrorism Released by Aethlon Medical, Inc.
11. Aethlon Medical to Present at the Singular Research Fifth Annual Best of the Uncovereds Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... YORK , Feb. 26, 2015 ... Latin America is estimated at 2.4 ... said that population growth, government insurance, newly insured ... in the region and will continue to propel ... on torresearch into the market and interviews with ...
(Date:2/26/2015)... BOSTON , Feb. 26, 2015 ... ("Columbia" or "the Company"), a specialty pharmaceutical company ... health, plans to initiate a Phase II clinical ... in women undergoing transvaginal pipelle-directed endometrial biopsy in ... pre-Investigational New Drug ("IND") submission feedback from the ...
(Date:2/26/2015)... Feb. 26, 2015  Technological advancements have ... effective, inexpensive and compact yet powerful solutions. ... small-scale, potent devices, lending momentum to the ... http://photos.prnewswire.com/prnh/20150225/177944LOGO New ... Nanomanufacturing, finds that nanomanufacturing will gain traction ...
Breaking Medicine Technology:Kalorama: Led by Brazil, IVD Test Market in Latin America Exceeds 2 Billion 2Kalorama: Led by Brazil, IVD Test Market in Latin America Exceeds 2 Billion 3Kalorama: Led by Brazil, IVD Test Market in Latin America Exceeds 2 Billion 4Columbia Laboratories to Initiate a Phase II Clinical Trial for COL-1077, Lidocaine Bioadhesive 10% Gel, in the Second Quarter of 2015 2Columbia Laboratories to Initiate a Phase II Clinical Trial for COL-1077, Lidocaine Bioadhesive 10% Gel, in the Second Quarter of 2015 3Revolutionary Nanomanufacturing Technology to Approach Commercialization by 2020 2Revolutionary Nanomanufacturing Technology to Approach Commercialization by 2020 3Revolutionary Nanomanufacturing Technology to Approach Commercialization by 2020 4
... II Study Demonstrates Significant,Additional Improvement for Patients ... /PRNewswire-FirstCall/ --,Indevus Pharmaceuticals, Inc. today announced that ... for pagoclone in persistent,developmental stuttering will be ... the New Clinical Drug Evaluation Unit (NCDEU), ...
... Insomnia on Healthcare System and,Worker Productivity, SAN ... Inc. announced today that results from several,research ... and transient,insomnia were presented this week at ... APSS highlights show that,insomnia is significantly under-diagnosed ...
Cached Medicine Technology:Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 2Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 3Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 4Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 5Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 6Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 7Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 8Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting 9Neurocrine Biosciences Announces New Research Studies Presented at,APSS Reveal Significant Under-Diagnosis of Insomnia 2Neurocrine Biosciences Announces New Research Studies Presented at,APSS Reveal Significant Under-Diagnosis of Insomnia 3Neurocrine Biosciences Announces New Research Studies Presented at,APSS Reveal Significant Under-Diagnosis of Insomnia 4Neurocrine Biosciences Announces New Research Studies Presented at,APSS Reveal Significant Under-Diagnosis of Insomnia 5
(Date:2/27/2015)... If there is one thing that drives parents into a ... at their child’s school. While head lice are not particularly ... of a nightmare for many parents as they see the ... their child’s classroom. Just when they think the problem is ... Local lice removal company, Lice Troopers , reports that ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Qualis ... management organizations, has been named a finalist in ... in recognition of outstanding commitment toward continuous improvement ... success in reducing hospital readmission rates through its ... “We are honored to receive this national recognition, ...
(Date:2/27/2015)... A fireplace can cause the average home to ... the chimney’s flue when the fireplace is not in use. ... solved with the introduction of a new small fireplace DraftStopper. ... 18" in diameter when inflated. It is quickly and easily ... damper. This size unit fits into round dampers, which are ...
(Date:2/27/2015)... The Connecticut Community for Addiction Recovery (CCAR) recently ... Drug Recovery Centers (ADRC), for its shared Recovery Oriented ... with the 2014 Commissioner’s Recognition Award by the CT ... Last year, ROES achieved the highest rate of employment ... from alcoholism and other drug addiction. More than ...
(Date:2/27/2015)... 27, 2015 Lewis Clinic Dentistry has extended ... 4PM to make its services available for patients who cannot ... from the Lewis Clinic Dentistry said, “Yes, we have extended ... on weekdays due to their busy schedules and work can ... to make more people’s lives beautiful and smiling.” He further ...
Breaking Medicine News(10 mins):Health News:Anxiety over head lice among Miami parents as surge in head lice cases reported by local lice removal company Lice Troopers 2Health News:Qualis Health Named Award Finalist for Care Transitions Work 2Health News:New DraftStopper from Tamarack Technologies Stops Heat Loss When Fireplace Not in Use 2Health News:Lewis Clinic Dentistry Extends Business Hours 2
... Aug. 22 , What: The American Academy of Actuaries, Public Interest Committee ... hear views on the disclosure of ... plans. The committee will use information obtained through ... board of directors on the issue is appropriately in the ...
... (Nasdaq: NXTM ), a leading manufacturer of ... of life analysis from,the FREEDOM study will be ... 2008 Annual Meeting taking place November 4-9, 2008,in ... (DHD),Improves Quality of Life (QoL) Measures, Depressive Symptoms ...
... Medicare Part B transaction ... its stores nationwide, FORT WORTH, Texas, Aug. 22 ... the retail pharmacy,industry, announced today that it will provide transaction ... state,Medicaid DME claims and clinical administration programs to Rite Aid. ...
... Group (CAHG),is proud to announce the promotion of ... eInnovation, Corbett Accel Healthcare,Group (CAHG). In his new ... Executive,Leadership Team of CAHG, and continue as Managing ... Melick is based in,CAHG,s Chicago office and will ...
... RESTON, Va.SNM and the American Society for Therapeutic ... this fall examining the impact of translational advances ... meeting, which takes place October 17-18, will bring ... young investigators in the emerging field of molecular ...
... CMS, Inc., an Elekta Company, and,worldwide leader ... received FDA 510(k) clearance for its new Atlas-Based,Autosegmentation ... distributing Atlas-Based Autosegmentation for clinical use in the,United ... spent creating and editing,patient contours, ABAS is a ...
Cached Medicine News:Health News:Actuaries to Host Forum on Public Pension Disclosures 2Health News:Actuaries to Host Forum on Public Pension Disclosures 3Health News:NxStage Announces Presentation of Data at the American Society of Nephrology's Renal Week 2008 Annual Meeting 2Health News:eRx Network to Provide Transaction Processing and Revenue Cycle Management Services to Rite Aid 2Health News:Corbett Accel Healthcare Group Announces Promotion of Geoff Melick to Executive Vice President, Interactive Marketing & eInnovation 2Health News:SNM and ASTRO team up to advance molecular imaging and cancer research 2Health News:CMS, Inc., an Elekta Company, Receives FDA 510(k) Clearance for Atlas-Based Autosegmentation Software 2
... difficile Panel is an enzyme immunoassay used ... antigen (glutamate dehydrogenase) and toxin A in ... as an aid in the diagnosis of ... of the Triage Microbiology product line, designed ...
ELISA for the detection of C. difficile toxin A in stool specimens...
... CCD cameras provide fast, accurate, reliable and ... quality at an excellent price. , , ... TOMEY TR-4000 Auto Refractor provides highly accurate ... is obtained simply by pushing a button. ...
... SP-3000 covers all needs regarding pachymetry in ... care., ,Compact design, colored touch-screen and "quick ... an "easy-to-use unit.,The wide measurement range from ... the possibility to measure very thin or ...
Medicine Products: